Abstract
Although a wide range of risk factors for coronary heart disease have been identified from population studies, these measures, singly or in combination, are insufficiently powerful to provide a reliable, noninvasive diagnosis of the presence of coronary heart disease. Here we show that pattern-recognition techniques applied to proton nuclear magnetic resonance (1H-NMR) spectra of human serum can correctly diagnose not only the presence, but also the severity, of coronary heart disease. Application of supervised partial least squares-discriminant analysis to orthogonal signal-corrected data sets allows >90% of subjects with stenosis of all three major coronary vessels to be distinguished from subjects with angiographically normal coronary arteries, with a specificity of >90%. Our studies show for the first time a technique capable of providing an accurate, noninvasive and rapid diagnosis of coronary heart disease that can be used clinically, either in population screening or to allow effective targeting of treatments such as statins.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Prediagnostic circulating metabolites in female breast cancer cases with low and high mammographic breast density
Scientific Reports Open Access 22 June 2021
-
1H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test
Scientific Reports Open Access 20 October 2020
-
Diagnosis of a model of Duchenne muscular dystrophy in blood serum of mdx mice using Raman hyperspectroscopy
Scientific Reports Open Access 16 July 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
National Statistics Series DH1 no. 31, Mortality Statistics (1998). The Stationery Office (UK Government), London, England.
Kjelsberg, M.O., Cutler, J.A. & Dolecek, T.A. Brief description of the Multiple Risk Factor Intervention Trial. Am. J. Clin. Nutr. 65 (Suppl. 1), 191S–195S (1997).
Kuller, L.H. et al. Cigarette smoking and mortality. MRFIT Research Group. Prev. Med. 20, 638–654 (1991).
Multiple Risk Factor Intervention Trial Research Group. Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Prev. Med. 15, 254–273 (1986).
McIlvain, H.E., McKinney, M.E., Thompson, A.V. & Todd, G.L. Application of the MRFIT smoking cessation program to a healthy, mixed-sex sample. Am. J. Prev. Med. 8, 165–170 (1992).
Ross, R. Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 340, 115–126 (1999).
Cullen, P., Funke, H., Schulte, H. & Assmann, G. Lipoproteins and cardiovascular risk—from genetics to CHD prevention. Eur. Heart J. 19 (Suppl. C), C5–C11 (1998).
Isles, C.G. & Paterson, J.R. Identifying patients at risk for coronary heart disease: Implications from trials of lipid-lowering drug therapy. Q.J. Med. 93, 567–574 (2000).
Nicholson, J.K., Lindon, J.C. & Holmes, E. 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181–1189 (1999).
Nicholson, J.K. & Wilson, I.D. High resolution proton magnetic resonance spectroscopy of biological fluids Prog. Nucl. Magn. Reson. Spectrosc. 21, 449–501 (1989).
Lindon, J.C., Holmes, E. & Nicholson, J.K. Pattern recognition methods and applications in biomedical magnetic resonance. Prog. Nucl. Magn. Reson. Spectrosc. 39, 1–40 (2001).
Lindon, J.C., Nicholson, J.K.N., Holmes, E. & Everett, J.R. Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids. Concepts Magn. Reson. 12, 289–320 (2000).
Holmes, E. et al. Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem. Res. Toxicol. 13, 471–478 (1999).
Storck, T., von Brevern, M.C., Behrens, C.K., Scheel, J. & Bach, A. Transcriptomics in predictive toxicology. Curr. Opin. Drug Discov. Devel. 5, 90–97 (2002).
Nicholson, J.K., Foxall, P.J., Spraul, M., Farrant, D.R. & Lindon, J.C. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal. Chem. 67, 793–811 (1995).
Ala-Korpela, M. 1H-NMR spectroscopy of human blood plasma. Prog. Nucl. Magn. Reson. Spectrosc. 27, 475–554 (1995).
Eriksson, L., Johansson, E., Kettanah-Wold, N. & Wold, S. Introduction to Multi and Megavariate Data Analysis Using Projection Methods (PCA and PLS-DA) (Umetrics AB, Malmo, Sweden, 1999).
Wold, S., Antti, H., Lindgren, F. & Ohman, J. Orthogonal signal correction of near-infrared spectra. Chemometrics Intelligent Lab. Systems 44, 175–185 (1998).
Ala-Korpela, M., Hiltunen, Y. & Bell, J.D. Quantification of biomedical NMR data using artificial neural network analysis: Lipoprotein lipid profiles from 1H NMR data of human plasma. NMR Biomed. 8, 235–244 (1995).
Otvos, J. In Handbook of Lipoprotein Testing (eds. Rifai, N., Warnick, R. & Dominiczak, M.) 497–508 (AACC Press, Washington DC, 1997).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
E.H., J.K.N and D.J.G. declare financial interest in this publication. These authors are named inventors on one or more patents filed partly as a result of the work described in this report, and these patents are assigned to Metabometrix Limited, a company in which E.H. and J.K.N. hold more than 5% equity stakes.
Supplementary information
Rights and permissions
About this article
Cite this article
Brindle, J., Antti, H., Holmes, E. et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 8, 1439–1445 (2002). https://doi.org/10.1038/nm1202-802
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1202-802
This article is cited by
-
Whole-Blood Metabolomics of a Rat Model of Repetitive Concussion
Journal of Molecular Neuroscience (2023)
-
Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson’s disease
Metabolic Brain Disease (2022)
-
Prediagnostic circulating metabolites in female breast cancer cases with low and high mammographic breast density
Scientific Reports (2021)
-
A strategy for advancing for population-based scientific discovery using the metabolome: the establishment of the Metabolomics Society Metabolomic Epidemiology Task Group
Metabolomics (2021)
-
1H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test
Scientific Reports (2020)